FMEA applied to the radiotherapy patient care process

被引:12
作者
Meyrieux, C. [1 ]
Garcia, R. [1 ]
Pourel, N. [1 ]
Mege, A. [1 ]
Bodez, V. [1 ]
机构
[1] Inst St Catherine, Sect Qual Gest Risques, F-84082 Avignon 2, France
来源
CANCER RADIOTHERAPIE | 2012年 / 16卷 / 07期
关键词
FMEA; Process; Risks; Radiotherapy; SECURITY;
D O I
10.1016/j.canrad.2012.07.188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. - Failure modes and effects analysis (FMEA), is a risk analysis method used at the Radiotherapy Department of Institute Sainte-Catherine as part of a strategy seeking to continuously improve the quality and security of treatments. Patients and methods. - The method comprises several steps: definition of main processes; for each of them, description for every step of prescription, treatment preparation, treatment application; identification of the possible risks, their consequences, their origins; research of existing safety elements which may avoid these risks; grading of risks to assign a criticality score resulting in a numerical organisation of the risks. Finally, the impact of proposed corrective actions was then estimated by a new grading round. Results. - For each process studied, a detailed map of the risks was obtained, facilitating the identification of priority actions to be undertaken. For example, we obtain five steps in patient treatment planning with an unacceptable level of risk, 62 a level of moderate risk and 31 an acceptable level of risk. Conclusion. - The FMEA method, used in the industrial domain and applied here to health care, is an effective tool for the management of risks in patient care. However, the time and training requirements necessary to implement this method should not be underestimated. (c) 2012 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:613 / 618
页数:6
相关论文
共 16 条
  • [1] Safety and quality assurance management in radiation oncology "What is the role for qualiticians?": Example of the Centre Alexis Vautrin
    Aigle, D.
    Sobczyk, C.
    Androni, M. -L.
    Peiffert, D.
    Beckendorf, V.
    Marchesi, V.
    Buchheit, I.
    Noel, A.
    [J]. CANCER RADIOTHERAPIE, 2009, 13 (6-7): : 455 - 457
  • [2] ASN, 2009, GUID ASN 5 GUID MAN
  • [3] ASN, 2009, GUID ASN 4 GUID AUT
  • [4] ASN-SFRO, 2008, ECH ASN SFRO PRIS CO
  • [5] From Crex mutualisation to clinical audit
    Debouck, F.
    Petit, H. -B.
    Lartigau, E.
    [J]. CANCER RADIOTHERAPIE, 2010, 14 (6-7): : 571 - 575
  • [6] A method for evaluating quality assurance needs in radiation therapy
    Huq, M. Saiful
    Fraass, Benedick A.
    Dunscombe, Peter B.
    Gibbons, John P., Jr.
    Ibbott, Geoffrey S.
    Medin, Paul M.
    Mundt, Arno
    Mutic, Sassa
    Palta, Jatinder R.
    Thomadsen, Bruce R.
    Williamson, Jeffrey F.
    Yorke, Ellen D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : S170 - S173
  • [7] Experience feed back committee in radiotherapy (CREx): a compulsory tool for security management evaluation at two years
    Lartigau, E.
    Coche-Dequeant, B.
    Dumortler, V.
    Giscard, S.
    Lacornerie, T.
    Lasue, A.
    Cheval, V.
    Martel, V.
    Malfait, B.
    Fuchs, A.
    Pestel, M.
    Damman, M.
    Forrest, M.
    [J]. CANCER RADIOTHERAPIE, 2008, 12 (6-7): : 610 - 613
  • [8] Lartigau E, 2006, RISQUES QUALITE, V2, P101
  • [9] Secure of the bi-site radiotherapy activity as part of the resumption of treatments in the Hospital of Epinal by the team of Alexis Vautrin Nancy Cancer Center
    Marchesi, V.
    Aigle, D.
    Peiffert, D.
    Noel, A.
    Simon, J. -M.
    [J]. CANCER RADIOTHERAPIE, 2009, 13 (08): : 740 - 743
  • [10] Matussiere F, 2008, RISQUE QUALITE, V4, P187